The executive team at ILiAD Biotechnologies has a history of experience in the medical and engineering industries. They have experience with startups, product development, and clinical research. They also have a strong educational background, with degrees from universities such as the University of Alabama at Birmingham, the University of Florida, and Ludwig-Maximilians-Universität München.
André Morais Campos
VP, Global Clinical Operations
Keith Rubin
Founder & CEO
Ken Solovay
Chief Operating Officer
Luis Rios-Nogales
Chief Development Officer, EVP
Marcel Thalen
VP, Drug Product Development
Peter Goldstein
Executive Director, Research &...
Stanley Kim
SVP, Intellectual Property & C...
Stephanie Noviello
Chief Medical Officer
View all